400 related articles for article (PubMed ID: 29400692)
21. Interacting network of Hippo, Wnt/β-catenin and Notch signaling represses liver tumor formation.
Kim W; Khan SK; Yang Y
BMB Rep; 2017 Jan; 50(1):1-2. PubMed ID: 27881216
[TBL] [Abstract][Full Text] [Related]
22. Hippo Signaling Suppresses Cell Ploidy and Tumorigenesis through Skp2.
Zhang S; Chen Q; Liu Q; Li Y; Sun X; Hong L; Ji S; Liu C; Geng J; Zhang W; Lu Z; Yin ZY; Zeng Y; Lin KH; Wu Q; Li Q; Nakayama K; Nakayama KI; Deng X; Johnson RL; Zhu L; Gao D; Chen L; Zhou D
Cancer Cell; 2017 May; 31(5):669-684.e7. PubMed ID: 28486106
[TBL] [Abstract][Full Text] [Related]
23. Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma.
Kim W; Khan SK; Liu Y; Xu R; Park O; He Y; Cha B; Gao B; Yang Y
Gut; 2018 Sep; 67(9):1692-1703. PubMed ID: 28866620
[TBL] [Abstract][Full Text] [Related]
24. Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects.
Rametta R; Mozzi E; Dongiovanni P; Motta BM; Milano M; Roviaro G; Fargion S; Valenti L
Int J Obes (Lond); 2013 Jul; 37(7):986-92. PubMed ID: 23147115
[TBL] [Abstract][Full Text] [Related]
25. Plk1 phosphorylation of IRS2 prevents premature mitotic exit via AKT inactivation.
Chen L; Li Z; Ahmad N; Liu X
Biochemistry; 2015 Apr; 54(15):2473-80. PubMed ID: 25830382
[TBL] [Abstract][Full Text] [Related]
26. The S100 calcium-binding protein A11 promotes hepatic steatosis through RAGE-mediated AKT-mTOR signaling.
Teng F; Jiang J; Zhang J; Yuan Y; Li K; Zhou B; Zhou X; Liu W; Zhang P; Liu D; Zheng M; Lu Y; Zhang H
Metabolism; 2021 Apr; 117():154725. PubMed ID: 33571540
[TBL] [Abstract][Full Text] [Related]
27. microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma.
Jiang XM; Yu XN; Liu TT; Zhu HR; Shi X; Bilegsaikhan E; Guo HY; Song GQ; Weng SQ; Huang XX; Dong L; Janssen HLA; Shen XZ; Zhu JM
Biomed Pharmacother; 2018 Sep; 105():1147-1154. PubMed ID: 30021351
[TBL] [Abstract][Full Text] [Related]
28. The critical role of AKT2 in hepatic steatosis induced by PTEN loss.
He L; Hou X; Kanel G; Zeng N; Galicia V; Wang Y; Yang J; Wu H; Birnbaum MJ; Stiles BL
Am J Pathol; 2010 May; 176(5):2302-8. PubMed ID: 20348245
[TBL] [Abstract][Full Text] [Related]
29. Dysregulation of PI3K and Hippo signaling pathways synergistically induces chronic pancreatitis via CTGF upregulation.
Tamura T; Kodama T; Sato K; Murai K; Yoshioka T; Shigekawa M; Yamada R; Hikita H; Sakamori R; Akita H; Eguchi H; Johnson RL; Yokoi H; Mukoyama M; Tatsumi T; Takehara T
J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34032634
[TBL] [Abstract][Full Text] [Related]
30. A functional interaction between Hippo-YAP signalling and SREBPs mediates hepatic steatosis in diabetic mice.
Shu Z; Gao Y; Zhang G; Zhou Y; Cao J; Wan D; Zhu X; Xiong W
J Cell Mol Med; 2019 May; 23(5):3616-3628. PubMed ID: 30821074
[TBL] [Abstract][Full Text] [Related]
31. Loss of protein tyrosine phosphatase 1B increases IGF-I receptor tyrosine phosphorylation but does not rescue retinal defects in IRS2-deficient mice.
Arroba AI; Revuelta-Cervantes J; Menes L; González-Rodríguez Á; Pardo V; de la Villa P; Burks DJ; Valverde ÁM
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4215-25. PubMed ID: 23702782
[TBL] [Abstract][Full Text] [Related]
32. Differential requirement of Hippo cascade during CTNNB1 or AXIN1 mutation-driven hepatocarcinogenesis.
Liang B; Wang H; Qiao Y; Wang X; Qian M; Song X; Zhou Y; Zhang Y; Shang R; Che L; Chen Y; Huang Z; Wu H; Monga SP; Zeng Y; Calvisi DF; Chen X; Chen X
Hepatology; 2023 Jun; 77(6):1929-1942. PubMed ID: 35921500
[TBL] [Abstract][Full Text] [Related]
33. The Hippo signaling pathway in liver regeneration and tumorigenesis.
Hong L; Cai Y; Jiang M; Zhou D; Chen L
Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):46-52. PubMed ID: 25476204
[TBL] [Abstract][Full Text] [Related]
34. Effects of Tyroserleutide on phosphatidylinositol 3'-kinase/AKT pathway in human hepatocellular carcinoma cell.
Fu Z; Ren L; Wei H; Lv J; Che X; Zhu Z; Jia J; Wang L; Lin G; Lu R; Yao Z
J Drug Target; 2014 Feb; 22(2):146-55. PubMed ID: 24147456
[TBL] [Abstract][Full Text] [Related]
35. MAF1 suppresses AKT-mTOR signaling and liver cancer through activation of PTEN transcription.
Li Y; Tsang CK; Wang S; Li XX; Yang Y; Fu L; Huang W; Li M; Wang HY; Zheng XF
Hepatology; 2016 Jun; 63(6):1928-42. PubMed ID: 26910647
[TBL] [Abstract][Full Text] [Related]
36. Irs2 inactivation suppresses tumor progression in Pten+/- mice.
Szabolcs M; Keniry M; Simpson L; Reid LJ; Koujak S; Schiff SC; Davidian G; Licata S; Gruvberger-Saal S; Murty VV; Nandula S; Efstratiadis A; Kushner JA; White MF; Parsons R
Am J Pathol; 2009 Jan; 174(1):276-86. PubMed ID: 19095950
[TBL] [Abstract][Full Text] [Related]
37. Dissecting the signaling pathways that mediate cancer in PTEN and LKB1 double-knockout mice.
Chen J; Zhang XD; Proud C
Sci Signal; 2015 Sep; 8(392):pe1. PubMed ID: 26329580
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of phosphatase and tensin homolog by hepatitis C virus core 3a in hepatocytes triggers the formation of large lipid droplets.
Clément S; Peyrou M; Sanchez-Pareja A; Bourgoin L; Ramadori P; Suter D; Vinciguerra M; Guilloux K; Pascarella S; Rubbia-Brandt L; Negro F; Foti M
Hepatology; 2011 Jul; 54(1):38-49. PubMed ID: 21465511
[TBL] [Abstract][Full Text] [Related]
39. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis.
Lee KP; Lee JH; Kim TS; Kim TH; Park HD; Byun JS; Kim MC; Jeong WI; Calvisi DF; Kim JM; Lim DS
Proc Natl Acad Sci U S A; 2010 May; 107(18):8248-53. PubMed ID: 20404163
[TBL] [Abstract][Full Text] [Related]
40. JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling.
Lei X; Xu JF; Chang RM; Fang F; Zuo CH; Yang LY
Oncotarget; 2016 Jun; 7(26):40266-40284. PubMed ID: 27259236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
